Arq, Inc. ARQ

Healthcare SIC 2890 - Miscellaneous Chemical Products NAICS Manufacturing › Chemical Manufacturing derived Nasdaq

Arq, Inc., together with its consolidated subsidiaries ("Arq", the "Company," "we," "us", or "our") is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions, primarily based on activated carbon ("AC"). Our proprietary AC products enable customers to reduce air, water, and soil contaminants, including mercury, per - and polyfluoroalkyl substances ("PFAS") and other pollutants, to meet the challenges of existing and pending air quality and water regulations. We manufacture and sell AC and other chemicals used to capture and remove impurities, contaminants and pollutants for the coal-fired power generation, industrial, water treatment, and water and soil remediation markets, which we collectively refer to as the advanced purification technologies ("APT") market.

Last close 1.75 2026-10-23
Market cap $76.4M 2026-06-30 share count
52-week range 1.54 - 7.03

Valuation FY2025 figures against the last close

P/S0.6x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-1.27

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Canada
Revenue by geography, 2 categories over 2 years. The same figures are in the table below. FY2025 United States, FY2025: 111.4M (92.6%) 93% United States Canada, FY2025: 8.9M (7.4%) 7% Canada FY2024 United States, FY2024: 101.1M (92.8%) 93% Canada, FY2024: 7.9M (7.2%) 7%
Region FY2025FY2024
United States $111.4M $101.1M
Canada $8.9M $7.9M

As the company reported it, from the “Segment Reporting - Schedule of Revenue from External Customers Attributed by country (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $120.3M$109.0M$99.2M$103.0M$100.3M$67.4M$70.1M$23.9M$45.4M$50.6M
Cost of revenue $86.8M$69.5M$67.3M—————$3.4M$1.7M
Gross profit $33.5M$39.4M$31.9M—————$41.9M$48.9M
R&D $7.3M$4.0M$3.3M$2.1M$400.0K$1.0M$200.0K—$157.0K-$648.0K
SG&A $22.6M$28.7M$34.1M$8.1M$7.1M$8.2M$8.1M$4.2M$4.0M$3.7M
Total operating expenses $86.5M$41.4M$45.2M$115.1M$95.4M$108.3M$85.0M$30.3M$49.5M$66.7M
Operating income -$53.0M-$2.0M-$13.3M-$12.1M$4.9M-$41.0M-$14.9M-$6.4M-$4.1M-$16.1M
Interest expense $2.4M$3.3M$3.0M$336.0K$1.5M$3.9M$7.2M$2.2M$3.0M$5.1M
Pre-tax income -$52.6M-$5.3M-$12.1M-$8.7M$76.1M-$13.8M$47.5M$45.9M$52.0M$36.7M
Income tax $12.0K$164.0K$153.0K$209.0K$15.7M$6.5M$12.0M$10.4M$24.2M$60.9M
Net income -$52.6M-$5.1M-$12.2M-$8.9M$60.4M-$20.3M$35.5M$35.5M$27.9M$97.7M
EPS, basic -1.27-0.14-0.42-0.483.31-1.121.961.781.304.40
EPS, diluted -1.27-0.14-0.42-0.483.27-1.121.931.761.294.34
Shares, diluted (wtd. avg.) 41.5M36.1M29.1M18.5M18.5M18.0M18.4M20.0M21.4M22.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $6.6M$13.5M$54.2M$76.4M$88.8M$35.9M$17.1M$23.8M$30.7M$26.9M
Receivables $15.0M$14.9M$16.2M$13.9M$12.6M$13.1M$7.4M$9.6M$1.1M$4.1M
Inventory $15.9M$19.3M$19.7M$17.8M$7.8M$9.9M$15.5M$21.8M$74.0K$16.0K
Total current assets $43.9M$52.4M$86.5M$105.7M$108.4M$62.0M$47.0M$59.8M$36.9M$38.9M
Property, plant and equipment ———————$42.7M$410.0K$735.0K
Other intangibles $570.0K$7.6M$7.9M$847.0K$1.2M$2.0M$4.2M$4.8M$805.0K$696.0K
Total assets $230.6M$284.4M$235.5M$181.2M$185.4M$146.7M$173.8M$159.7M$82.6M$107.3M
Accounts payable $15.3M$21.0M$14.6M$16.1M$16.5M$7.8M$8.0M$6.2M$1.0M$1.9M
Short-term debt $20.0M$15.5M$2.7M$1.1M$1.0M$18.4M$23.9M$24.1M—$0
Total current liabilities $42.3M$44.7M$23.0M$23.9M$22.6M$42.5M$39.3M$40.7M$6.9M$23.7M
Long-term debt $8.5M$9.4M$18.3M$3.5M$3.2M$5.4M$20.4M$50.1M$0—
Total liabilities $62.6M$67.1M$57.1M$41.2M$38.1M$61.5M$65.5M$91.7M$9.2M$31.1M
Retained earnings $13.8M$66.4M$71.5M$83.9M$92.9M$32.5M$57.3M$12.9M-$15.5M-$43.4M
Total equity $168.0M$217.3M$178.4M$140.0M$147.3M$85.2M$108.3M$67.9M$73.5M$76.2M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$2.7M$10.5M-$16.7M-$6.1M$26.0M$54.0M$62.3M-$9.9M-$11.7M-$18.3M
Depreciation and amortisation $11.7M$8.6M$10.5M$6.4M$7.9M$8.5M$7.4M$723.0K$789.0K$979.0K
Stock-based compensation $3.4M$2.7M$2.6M$2.0M$1.9M$2.5M$2.0M$2.5M$2.2M$2.9M
Capital expenditure $8.6M$85.2M$27.5M$8.9M$6.2M$6.7M$7.9M$467.0K$428.0K$289.0K
Investing cash flow -$8.2M-$85.1M-$28.5M-$4.6M$44.4M-$7.5M-$13.2M-$16.5M$48.4M$39.9M
Financing cash flow $3.7M$42.7M$22.9M-$1.7M-$17.5M-$27.7M-$55.7M$19.5M-$32.9M-$15.7M
Dividends paid ——$0$45.0K$93.0K$5.0M$18.3M$20.2M$15.7M$0
Buybacks ————$0$159.0K$5.8M$25.3M$16.4M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001515156-26-000052.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -100M -50M 0 50M 100M 150M Revenue, FY2016: 50.6M Gross profit, FY2016: 48.9M Net income, FY2016: 97.7M Revenue, FY2017: 45.4M Gross profit, FY2017: 41.9M Net income, FY2017: 27.9M Revenue, FY2018: 23.9M Net income, FY2018: 35.5M Revenue, FY2019: 70.1M Net income, FY2019: 35.5M Revenue, FY2020: 67.4M Net income, FY2020: -20.3M Revenue, FY2021: 100.3M Net income, FY2021: 60.4M Revenue, FY2022: 103M Net income, FY2022: -8.9M Revenue, FY2023: 99.2M Gross profit, FY2023: 31.9M Net income, FY2023: -12.2M Revenue, FY2024: 109M Gross profit, FY2024: 39.4M Net income, FY2024: -5.1M Revenue, FY2025: 120.3M Gross profit, FY2025: 33.5M Net income, FY2025: -52.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $50.6M $45.4M $23.9M $70.1M $67.4M $100.3M $103.0M $99.2M $109.0M $120.3M
Gross profit $48.9M $41.9M — — — — — $31.9M $39.4M $33.5M
Net income $97.7M $27.9M $35.5M $35.5M -$20.3M $60.4M -$8.9M -$12.2M -$5.1M -$52.6M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Item 5.02
  • Other event Item 8.01
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2890

TickerCompanyMarket capP/ERevenue growth
ESI Element Solutions Inc $8.09B 42.0x 3.8%
CBT CABOT CORP $3.81B 12.3x -7.0%
WDFC WD 40 CO $2.85B 31.8x 5.0%
FTK FLOTEK INDUSTRIES INC/CN/ $865.7M 28.5x 26.9%
OEC Orion S.A. $308.0M — -3.8%
ASPI ASP Isotopes Inc. $298.2M — 475.5%
FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC $81.9M 106.8x 0.7%
ZTEK Zentek Ltd. — — —